• 主题
高级搜索  >
历史搜索 清空历史
首页> 美国卫生研究院文献>Journal of Diabetes Science and Technology >Mobile Technology: Smart Telemedicine Support for Continuous Glucose Monitoring: The Embryo of a Future Global Agent for Diabetes Care
【2h】

Mobile Technology: Smart Telemedicine Support for Continuous Glucose Monitoring: The Embryo of a Future Global Agent for Diabetes Care

机译：移动技术：连续血糖监测的智能远程医疗支持：未来糖尿病护理全球代理商的雏形

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Although current systems for continuous glucose monitoring (CGM) are the result of progressive technological improvement, and although a beneficial effect on glucose control has been demonstrated, few patients are using them. Something similar has happened to telemedicine (TM); in spite of the long-term experience, which began in the early 1980s, no TM system has been widely adopted, and presential visits are still almost the only way diabetologists and patients communicate. The hypothesis developed in this article is that neither CGM nor TM will ever be routinely implemented separately, and their consideration as essential elements for standard diabetes care will one day come from their integration as parts of a telemedical monitoring platform. This platform, which should include artificial intelligence for giving decision support to patients and physicians, will represent the core of a more complex global agent for diabetes care, which will provide control algorithms and risk analysis among other essential functions.
机译：尽管当前的连续血糖监测（CGM）系统是技术进步的结果，并且尽管已证明对血糖控制具有有益作用，但很少有患者使用它们。远程医疗（TM）发生了类似的情况。尽管始于1980年代初期的长期经验，但TM系统尚未得到广泛采用，即时访问仍然几乎是糖尿病学家和患者沟通的唯一途径。本文中提出的假设是，CGM和TM都不会被单独例行实施，并且有一天它们将被视为标准糖尿病护理的基本要素，这将有赖于将它们集成为远程医疗监控平台的一部分。该平台应包括为患者和医生提供决策支持的人工智能，它将代表更复杂的全球糖尿病护理代理商的核心，该代理商将提供控制算法和风险分析以及其他基本功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号